Inhibition of oxygen scavengers realized by peritoneal macrophages: An adhesion prevention target?

Mynbaev O.A. ^{1, 2, 3, 4, 5} , Eliseeva M.Y. ^{1, 2} , Mynbaev O.A. ^{1, 2, 3, 4, 5} , Kadayifci O.T.^{1, 4, 6} , Benhidjeb T.¹

International Journal of Nanomedicine

Dove Medical Press Ltd.

1

English

5259-5260

Published

External link

10.2147/IJN.S76152

9

2014

• ¹ The International Translational Medicine and Biomodeling Research team, MIPT center for human physiology studies, Laboratory of C Cellular and Molecular Technologies, The Department of Applied Mathematics, Moscow Institute of Physics and Technology (State University), Moscow Region, United States
• ² The Department of Obstetrics, Gynecology and Reproductive Medicine, Peoples’ Friendship University of Russia, Moscow, United States
• ³ Laboratory of Pilot Projects, Moscow State University of Medicine and Dentistry, Moscow, United States
• ⁴ The New European Surgical Academy, Berlin, Germany
• ⁵ Onkim Stem Cell Technologies Inc, Istanbul, Turkey
• ⁶ Department of Surgery, Burjeel Hospital, Abu Dhabi, United Arab Emirates

epigallocatechin gallate; fibrin glue; nanofiber; nanoparticle; polyglactin; polypropylene; reactive oxygen metabolite; tissue adhesive; catechin; lactic acid; polyglycolic acid; protective agent; antioxidant activity; cell isolation; disease severity; drug efficacy; drug response; Letter; neovascularization (pathology); nonhuman; partial thromboplastin time; peritoneum macrophage; sclerosis; tea; tissue adhesion; wound healing; analogs and derivatives; animal; chemistry; male; Tissue Adhesions; Animals; Catechin; Lactic Acid; Male; Nanofibers; Polyglycolic Acid; Protective Agents; Tissue Adhesions